Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
D000135:Acid Phosphatase / Q000097:blood*; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D001708:Biopterins / Q000031:analogs & derivatives / Q000097:blood*; D002135:Calcium-Binding Proteins / Q000097:blood*; D004796:Clinical Enzyme Tests; D019411:Clinical Laboratory Techniques; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D019798:Neopterin; D015675:Osteocalcin; D010455:Peptides / Q000032:analysis*; D011467:Prostate / Q000201:enzymology*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis; D011621:Pteridines / Q000097:blood*; D011863:Radioimmunoassay / Q000379:methods; D019396:Tissue Polypeptide Antigen; D014812:Vitamin K / Q000097:blood*
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D002135:Calcium-Binding Proteins; D010455:Peptides; D011621:Pteridines; D019396:Tissue Polypeptide Antigen; D015675:Osteocalcin; D014812:Vitamin K; D001708:Biopterins; D019798:Neopterin; D000135:Acid Phosphatase